Author(s): Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, et al.
Background:Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes systemic AA amyloidosis, a serious complication of many chronic inflammatory disorders. Little is known about the natural history of AA amyloidosis or its response to treatment.
Methods:We evaluated clinical features, organ function, and survival among 374 patients with AA amyloidosis who were followed for a median of 86 months. The SAA concentration was measured serially, and the amyloid burden was estimated with the use of whole-body serum amyloid P component scintigraphy. Therapy for inflammatory diseases was administered to suppress the production of SAA.
Results:Median survival after diagnosis was 133 months; renal dysfunction was the predominant disease manifestation. Mortality, amyloid burden, and renal prognosis all significantly correlated with the SAA concentration during follow-up. The risk of death was 17.7 times as high among patients with SAA concentrations in the highest eighth, or octile, (>or=155 mg per liter) as among those with concentrations in the lowest octile (<4 mg per liter); and the risk of death was four times as high in the next-to-lowest octile (4 to 9 mg per liter). The median SAA concentration during follow-up was 6 mg per liter in patients in whom renal function improved and 28 mg per liter in those in whom it deteriorated (P<0.001). Amyloid deposits regressed in 60% of patients who had a median SAA concentration of less than 10 mg per liter, and survival among these patients was superior to survival among those in whom amyloid deposits did not regress (P=0.04).
Conclusions:The effects of renal dysfunction dominate the course of AA amyloidosis, which is associated with a relatively favorable outcome in patients with SAA concentrations that remain in the low-normal range (<4 mg per liter).
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/17554117
Author(s): Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE
Author(s): Hakoda M, Oiwa H, Kasagi F, Masunari N, Yamada M, et al.
Author(s): Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, et al.
Author(s): Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M
Author(s): Smolen JS, Aletaha D
Author(s): Bakker MF, Jacobs JW, Verstappen SM, Bijlsma JW
Author(s): Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F
Author(s): Toyoshima H, Kusaba T, Yamaguchi M
Author(s): Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al.
Author(s): Laakso M, Isomäki H, Mutru O, Koota K
Author(s): Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, et al.
Author(s): Yamanaka H, Tohma S
Author(s): Mutru O, Laakso M, Isomäki H, Koota K
Author(s): Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, et al.